Implementation strategy for AI quality assurance in substance use treatment
Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder Treatment
This study is testing a new way to use an AI tool that helps improve treatment for substance use disorders by making sure that addiction services in Oregon and Indiana follow best practices.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 470 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 1 site (La Jolla, California) |
| Trial ID | NCT05344534 on ClinicalTrials.gov |
What this trial studies
This project tests a strategy to implement and sustain the Lyssn AI quality assurance platform, which supports the use of Motivational Interviewing and evidence-based practices for treating substance use disorders. The Leadership and Organizational Change for Implementation - System Level (LOCI-SL) strategy engages policymakers and funders to improve leadership and provider attitudes within addiction service systems. By aligning state-level policies with organizational strategies, the project aims to enhance the implementation climate for evidence-based practices across community-based behavioral health organizations in Oregon and Indiana.
Who should consider this trial
Good fit: Ideal candidates include stakeholders from state health authorities, executives at treatment agencies, clinic managers, and counselors involved in substance use and mental health treatment.
Not a fit: Patients who are not involved in the treatment process or do not work within the substance use disorder and mental health treatment systems may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality and effectiveness of substance use disorder treatments through better implementation of evidence-based practices.
How similar studies have performed: Other studies have shown success with similar implementation strategies, indicating potential for effective outcomes in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
1. Stakeholders from Oregon Health Authority (OHA), Oregon Alcohol and Drug Policy Commission (ADPC), staff at provider/payer advocacy organizations (e.g., CCO Oregon, Oregon Council for Behavioral Health), and relevant managed care organizations (Coordinated Care Organizations, CCOs), Indiana Department of Mental Health and Addiction (DMHA), or Indiana Department of Child Services (DCS). 2. Executives and/or managers at participating substance use disorder and/or mental health treatment agencies. 3. Clinic managers/supervisors in clinics that provide substance use disorder and/or mental health treatment. 4. Counselors (i.e., service providers) employed at participating agencies that provide substance use disorder and/or mental health treatment.
Where this trial is running
La Jolla, California
- UC San Diego — La Jolla, California, United States (Recruiting)
Study contacts
- Study coordinator: Gregory Aarons, PhD
- Email: gaarons@health.ucsd.edu
- Phone: 8589667703
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.